Literature DB >> 6693014

Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis.

H Ohkubo, K Okuda, S Iida, K Ohnishi, S Ikawa, I Makino.   

Abstract

To study the mechanism for the elevation of serum bile acids in liver cirrhosis, bile acid concentrations were measured in the portal, superior mesenteric, and splenic veins, using percutaneous transhepatic catheterization, and compared with those of peripheral veins in 41 patients with mild to moderately advanced cirrhosis. The demonstrated gradient of bile acid concentration was superior mesenteric vein greater than portal vein greater than peripheral vein nearly equal to splenic vein, suggesting that the superior mesenteric vein is the main route of transport for the intestinally absorbed bile acids. Bile acid concentrations in peripheral vein were correlated with the measured portal and splenic vein shunt indexes. The ursodeoxycholic acid oral tolerance test carried out in 10 patients during portal vein catheterization demonstrated that hepatic extraction of this bile acid was correlated with indocyanine green clearance and that it was inversely correlated with portal vein shunt index. These findings are consistent with the view that distorted hepatic blood flow has a significant role in elevating serum bile acid, at least in patients with moderately advanced liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693014

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

Review 1.  Portal hypertension--25 years of progress.

Authors:  B R MacDougall; D Westaby; L A Blendis
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 2.  Clinical pharmacokinetics in patients with liver disease.

Authors:  A J McLean; D J Morgan
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

3.  Combined measurements of serum bile acid level and splenic volume may be useful to noninvasively assess portal venous pressure.

Authors:  Hiromitsu Hayashi; Toru Beppu; Hirohisa Okabe; Hidetoshi Nitta; Katsunori Imai; Koichi Doi; Akira Chikamoto; Hideo Baba
Journal:  J Gastroenterol       Date:  2012-05-09       Impact factor: 7.527

Review 4.  Bile acids regulate cardiovascular function.

Authors:  Sandeep Khurana; Jean-Pierre Raufman; Thomas L Pallone
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

5.  Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.

Authors:  J Reichen; B Egger; N Ohara; T B Zeltner; T Zysset; A Zimmermann
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 6.  Dose adjustment in patients with liver disease.

Authors:  Fabiola Delcò; Lydia Tchambaz; Raymond Schlienger; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease.

Authors:  S Krähenbühl; P Grass; A Surve; K Kutz; J Reichen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Serum bile acids and oral ursodeoxycholic acid tolerance test in the diagnosis of esophageal varices.

Authors:  M Kadohara; H Kawasaki; C Hirayama
Journal:  Gastroenterol Jpn       Date:  1987-10

9.  Role of bile acids in splanchnic hemodynamic response to chronic portal hypertension.

Authors:  S H Thomas; T Joh; J N Benoit
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

10.  Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension.

Authors:  S K Sarin; R J Groszmann; P G Mosca; M Rojkind; M J Stadecker; R Bhatnagar; A Reuben; Y Dayal
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.